Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility Patients

Next Previous
Trial Profile

Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility Patients

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 29 Jan 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Letrozole (Primary) ; Menotropin; Recombinant follicle-stimulating hormone
  • Indications Infertility
  • Focus Therapeutic Use

Most Recent Events

  • 07 Jan 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
  • 09 May 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 May 2015 to 1 Aug 2015.
  • 09 May 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Apr 2015 to 1 Jul 2015.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top